Please login to the form below

Not currently logged in
Email:
Password:

Zolgensma

This page shows the latest Zolgensma news and features for those working in and with pharma, biotech and healthcare.

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Final results from Novartis’ phase 3 SPR1NT trial assessing Zolgensma (onasemnogene abeparvovec) have been published in Nature Medicine. ... Zolgensma is currently the only approved gene therapy for the treatment of SMA and is the only SMA treatment

Latest news

More from news
Approximately 23 fully matching, plus 40 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....